Avodart

   
Google
 
Web NewDrugInformation.com

Avodart


Drug - Avodart
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dutasteride
Multiple ingredients are in alphabetical order.

Strength - 0.5MG
The potency of the active ingredient(s), Dutasteride. May repeat for multiple part products.

Applicant - GLAXOSMITHKLINE
The firm name holding legal responsibility for Avodart. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021319
The FDA assigned number to Avodart. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Avodart. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 20, 2001
The date Avodart was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Avodart. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Avodart is in. Format is RX, OTC, DISCN.

Applicant Full Name - Glaxosmithkline
The full name of the firm holding legal responsibility for the new application of Avodart.

Avodart